Transforming growth factor-β (TGF-β) and connective tissue growth factor (CCN2, CTGF) induce a mesenchymal-like phenotype in type II alveolar epithelial cells in lung fibrosis.

Angela Tam, DJ Abraham(The Royal Free Hospital), Audrey Dooley, CP Denton(The Royal Free Hospital), A Leask, Sonali Sonnylal, B. de Crombrugghe, Jill T. Norman(The Royal Free Hospital)

Unknown

December 1, 2011

Cited by 0

Related Papers

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

|Annals of the Rheumatic Diseases|2003|769

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

|Annals of the Rheumatic Diseases|2010|503

Integrated genomic characterization of endometrial carcinoma

|Carolina Digital Repository (University of North Carolina at Chapel Hill)|2013|415

Open-Label Trial of Anti-TNF-α in Dermato- and Polymyositis Treated Concomitantly with Methotrexate

|European Neurology|2008|99

Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test

|Annals of the Rheumatic Diseases|2006|98